chr10-102226568-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152310.3(ELOVL3):āc.20T>Gā(p.Val7Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,613,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152310.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELOVL3 | NM_152310.3 | c.20T>G | p.Val7Gly | missense_variant | 1/4 | ENST00000370005.4 | NP_689523.1 | |
ELOVL3 | XM_011540245.2 | c.20T>G | p.Val7Gly | missense_variant | 2/5 | XP_011538547.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELOVL3 | ENST00000370005.4 | c.20T>G | p.Val7Gly | missense_variant | 1/4 | 1 | NM_152310.3 | ENSP00000359022 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152154Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251332Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135832
GnomAD4 exome AF: 0.000153 AC: 223AN: 1461698Hom.: 0 Cov.: 30 AF XY: 0.000153 AC XY: 111AN XY: 727158
GnomAD4 genome AF: 0.000151 AC: 23AN: 152154Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.20T>G (p.V7G) alteration is located in exon 1 (coding exon 1) of the ELOVL3 gene. This alteration results from a T to G substitution at nucleotide position 20, causing the valine (V) at amino acid position 7 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at